hotspot -WSS

hotspot

author：entertainment 2025-10-02 13:40:49 - browse：92456

James Comer -- coverage from STAT — Rep. James Comer, chair of the House Oversight Committee Kevin Dietsch/Getty Images

WASHINGTON — Congress wants to reform PBM business practices to help lower the cost of medicines — but don’t think they’ve forgotten drugmakers have a role in high drug prices.

Two lawmakers, including a Republican, questioned PhRMA Chief Operating Officer Lori Reilly about just how much her group was spending on its major campaigns against PBMs this year. Both Reps. Summer Lee (D-Pa.) and Eric Burlison (R-Mo.) used their time to question drugmakers over their spending on lawsuits against Medicare drug price negotiation and ad campaigns against pharmacy benefit managers.

Although Lee started off bashing PBMs for the fees they charge drugmakers, she quickly aimed her fire back on pharma. She said brand drugmakers charge Americans double what they charge other countries, and she asked why several drugmakers are suing the federal government over Medicare’s drug price negotiation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： AI can decode, harness the power of the humane immune system

WSS

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Why Charlie Gard's case is so disturbing to Americans

A Q&A with the global head of Boehringer Ingelheim's innovation unit

The future of health care in the House

Chan Zuckerberg Biohub Chicago to focus on inflammation

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Wikipedia

hotspot

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

A virus, fished out of a lake, may have saved a man’s life

Jerome Adams on the need for new antivirals for Covid

Bill would stop addiction treatment from triggering child abuse inquiry

After affirmative action ruling, medical educators look to 'holistic review'

Why CTE doesn’t keep Americans from enjoying the Super Bowl

Dobbs anniversary: the lost opportunity of abortion as health care

Senate panel eyes new effort on drug shortages

Peter Hotez and the public health issue of online harassment

AI gets buy

focus

Texas Medical Board asked to define abortion emergency exception

Was Amgen transparent enough on FDA's concern on cancer drug?

Sana to lay off nearly a third of staff, de

A single Democrat is willing to weaken Medicare negotiation power

FDA authorizes Novavax’s updated Covid

Physician executives need more than on

entertainment

hotspot

entertainment

explore